Justifying Your Return on Investment with Integrated Medication Use Technology
Space is limited, and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis. Food and beverages are not provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session.
Adoption of healthcare technology solutions continues to increase, and thoughtful implementation and use of these systems can support safe and efficient workflow. However, despite our best efforts, at times we may fail to recognize or anticipate unintended consequences before they cause a problem or result in an error. As such, suboptimal use of healthcare technologies presents safety challenges. In order to support growth in utilization of technology solutions, we need to ensure organizations capitalize on their value and safety benefits. This symposium will educate pharmacists about the unintended consequences of suboptimal use of healthcare technologies, how to justify the return on investment for expansion of technologies, and by what means to identify gaps in best practices related to the use of automated dispensing cabinets, one of the most widely deployed forms of integrated medication use technology. The symposium is designed to challenge the status quo, draw attention to at-risk processes, and help pharmacists see technology through a safety lens.
- Pharmacy Technicians
Following completion of this activity, participants will be able to:
- Describe risks and errors related to suboptimal use of different healthcare technologies.
- Identify a strategic approach to optimizing the safe use of medication use technologies.
- Analyze the return on investment of medication technologies.
- Recognize the ISMP Best Practice Guidelines that can be utilized to identify gaps in practice and promote safe use of technology.
Introduction and Overview:
Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP, President, ISMP
Unintended Consequences of Healthcare Technologies
Christina Michalek, BS, RPh, FASHP, Medication Safety Specialist, ISMP
From the Front Line: Optimizing Safe Use of Healthcare Technologies
Gee Mathen, BS, Assistant Director of Pharmacy for Application and Technical Services, Texas Children's Hospital
Finding the Gaps: Best Practice Guidelines for Use of Technologies
Susan Paparella, MSN, RN, Vice President, ISMP
Nistha Shah, PharmD, ISMP International Medication Safety Management Fellow
This activity is supported by Omnicell.
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-510-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date December 10, 2019). This CE activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 10, 2020 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.